Patent intelligence · DE
DE 102011115690
Quetiapin enthaltende Formulierungen
Quetiapin enthaltende Formulierungen
Patent details — DE 102011115690
- Jurisdiction
- DE
- Status
- granted
- Grant date
- Apr 11, 2013
- Expiration
- Apr 6, 2033
- Applicant
- ACINO PHARMA AG [CH]
- CPC classes
- A61K 9/ 16 A I, A61K 9/ 22 A I, A61K 31/ 554 A I, A61K/31554
Quick answer
DE 102011115690 (Quetiapin enthaltende Formulierungen) is held by ACINO PHARMA AG [CH]. Status: granted. Granted Apr 11, 2013. Expires Apr 6, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ACINO PHARMA AG [CH]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 16 A I, A61K 9/ 22 A I, A61K 31/ 554 A I, A61K/31554, A61K/91623, A61K/91635
More from ACINO PHARMA AG [CH]
Related pharmaceutical patents in our USPTO index.
-
CH 711279
Verpacktes Arzneimittel, umfassend eine Retardformulierung von Naloxon oder einem pharmazeutisch verträglichen Salz davon, und eine Verpackung.
granted -
DE 202016005375
Verminderung der Deallylierung von Naloxon während der Lagerung einer naloxonhaltigen Retardformulierung
granted -
EP 3067050
TRANSDERMALES THERAPEUTISCHES SYSTEM MIT EINEM OVERTAPE MIT ZWEI HAFTSCHICHTEN
granted -
WO 2016001312
DISPOSITIF POUR LA FABRICATION DE TIMBRES PHARMACEUTIQUES
granted -
WO 2015165821
VERFAHREN UND VORRICHTUNG ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG
granted -
US 2015112285
Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof
granted -
EP 2804734
GITTERVERLUSTREDUKTION BEI PFLASTERHERSTELLUNG
granted -
EP 2682113
Verschließen wirkstoffhaltiger Laminate
granted
Frequently asked questions
What is US patent 102011115690?
DE 102011115690 (Quetiapin enthaltende Formulierungen) is held by ACINO PHARMA AG [CH]. Status: granted. Granted Apr 11, 2013. Expires Apr 6, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns DE 102011115690?
ACINO PHARMA AG [CH] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does DE 102011115690 expire?
Our index shows an expiration date of Apr 6, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.